Lymphocytopenia in severe COVID-19 patients reduced the total number of effectors CD8+ T cell subsets and the analysis of T cell activation markers (11, 22, 23) indicated ineffective T cell response in severe COVID-19 patients. The gene discussed is CD8A; the disease is COVID-19.